Cargando…

Impact of BRAF(V600E) mutation on aggressiveness and outcomes in adult clonal histiocytosis

Histiocytoses encompass a wide spectrum of diseases, all characterized by tissue infiltration by CD68+ histiocytes. Most adult histiocytoses are considered clonal diseases because they highlight recurrent somatic mutations in the MAP-kinase pathway gene, primarily BRAF. The presence of BRAF mutation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Razanamahery, Jerome, Godot, Amelie, Leguy-Seguin, Vanessa, Samson, M., Audia, Sylvain, Bonnotte, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556468/ https://www.ncbi.nlm.nih.gov/pubmed/37809108 http://dx.doi.org/10.3389/fimmu.2023.1260193

Ejemplares similares

Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing BRAF(V600E) -Mutated Erdheim–Chester Disease: A Case Report
por: Razanamahery, Jérôme, et al.
Publicado: (2022)

T-cell response to 3 doses of Sars-Cov2 BNT162b2 Pfizer vaccine in long term rituximab treated patients
por: Heitz, Jade, et al.
Publicado: (2022)

Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients
por: Estève, Clémentine, et al.
Publicado: (2017)

BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay
por: Tatsuno, Michiko, et al.
Publicado: (2016)

Dabrafenib, alone or in combination with trametinib, in BRAF V600–mutated pediatric Langerhans cell histiocytosis
por: Whitlock, James A., et al.
Publicado: (2023)

Venous thromboembolic events during warm autoimmune hemolytic anemia
por: Audia, Sylvain, et al.
Publicado: (2018)

BRAF V600E-Positive Congenital Multisite Langerhans Cell Histiocytosis
por: Prada Avella, Maria Camila, et al.
Publicado: (2020)

Machine learning-based radiomics for predicting BRAF-V600E mutations in ameloblastoma
por: Li, Wen, et al.
Publicado: (2023)

Synchronous and Metachronous Thyroid Cancer in Relation to Langerhans Cell Histiocytosis; Involvement of V600E BRAF-Mutation?
por: Moschovi, Maria, et al.
Publicado: (2015)

Clinicopathological features and BRAF(V600E) mutations in patients with isolated hypothalamic-pituitary Langerhans cell histiocytosis
por: Huo, Zhen, et al.
Publicado: (2016)

Cellular distribution of mutations and association with disease risk in Langerhans cell histiocytosis without BRAF(V600E)
por: Milne, Paul, et al.
Publicado: (2022)

Etiologies and prognostic factors of leukocytoclastic vasculitis with skin involvement: A retrospective study in 112 patients
por: Bouiller, Kévin, et al.
Publicado: (2016)

Emerging Therapies in Immune Thrombocytopenia
por: Audia, Sylvain, et al.
Publicado: (2021)

Apparent Lack of BRAF(V600E) Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8(+) T Cells in Langerhans Cell Histiocytosis
por: Kemps, Paul G., et al.
Publicado: (2020)

Langerhans Cell Histiocytosis, Non-Langerhans histiocytosis and concurrent Papillary Thyroid Carcinoma with BRAF V600E mutations: A case report and literature review
por: Wake, Laura, et al.
Publicado: (2019)

Effectiveness and Safety of Dabrafenib in the Treatment of 20 Chinese Children with BRAF(V600E)-Mutated Langerhans Cell Histiocytosis
por: Yang, Ying, et al.
Publicado: (2021)

Specific blood monocyte distribution in histiocytoses correlates with vascular involvement and disease activity
por: Razanamahery, Jerome, et al.
Publicado: (2023)

BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate
por: Bates, Sara V., et al.
Publicado: (2013)

Lineage switching of the cellular distribution of BRAF(V600E) in multisystem Langerhans cell histiocytosis
por: Milne, Paul, et al.
Publicado: (2022)

Colon metastasis from lung adenocarcinoma with BRAF V600E mutation: A case report
por: Luo, Yuhao, et al.
Publicado: (2022)

Adult Onset of BRAF(V600E)-Mutated Langerhans Cell Histiocytosis with Cutaneous Involvement Successfully Diagnosed by Immunohistochemical Staining
por: Tono, Hisayuki, et al.
Publicado: (2015)

Genetic homogeneity of adult Langerhans cell histiocytosis lesions: Insights from BRAF(V600E) mutations in adult populations
por: Selway, Joanne Louise, et al.
Publicado: (2017)

Multisystemic Pediatric Langerhans cell histiocytosis: a comprehensive clinico-pathological and BRAF V600E mutation study at autopsy
por: Kapatia, Gargi, et al.
Publicado: (2020)

Case Report: Evolution of a Severe Vascular Refractory Form of ECD Requiring Liver Transplantation Correlated With the Change in the Monocyte Subset Analysis
por: Razanamahery, Jérôme, et al.
Publicado: (2021)

BRAF V600E mutation correlates with suppressive tumor immune microenvironment and reduced disease-free survival in Langerhans cell histiocytosis
por: Zeng, Kaixuan, et al.
Publicado: (2016)

Frequency detection of BRAF V600E mutation in a cohort of pediatric langerhans cell histiocytosis patients by next-generation sequencing
por: Feng, Shunqiao, et al.
Publicado: (2021)

The role of BRAF V600 mutation in melanoma
por: Ascierto, Paolo A, et al.
Publicado: (2012)

Association between clinicopathologic characteristics and BRAF(V600E) expression in Chinese patients with Langerhans cell histiocytosis
por: Huang, Hui, et al.
Publicado: (2019)

A study of pathological characteristics and BRAF V600E status in Langerhans cell histiocytosis of Vietnamese children
por: Phan, Thu Dang Anh, et al.
Publicado: (2021)

BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
por: Del Bufalo, Francesca, et al.
Publicado: (2018)

New somatic BRAF splicing mutation in Langerhans cell histiocytosis
por: Héritier, Sébastien, et al.
Publicado: (2017)

Comparative Methods to Improve the Detection of BRAF V600 Mutations in Highly Pigmented Melanoma Specimens
por: Frouin, Eric, et al.
Publicado: (2016)

Circulating cell-free BRAF V600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis
por: Cui, Lei, et al.
Publicado: (2020)

BRAF V600E and Pten deletion in mice produces a histiocytic disorder with features of Langerhans cell histiocytosis
por: Nelson, David S., et al.
Publicado: (2019)

BRAF V600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis
por: Kudo, Ko, et al.
Publicado: (2022)

Impact of MAPK Pathway Activation in BRAF(V600) Melanoma on T Cell and Dendritic Cell Function
por: Ott, Patrick A., et al.
Publicado: (2013)

Lineage-coupled clonal capture identifies clonal evolution mechanisms and vulnerabilities of BRAF(V600E) inhibition resistance in melanoma
por: Zhang, Ze-Yan, et al.
Publicado: (2022)

BRAF(V600E) promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis
por: Sconocchia, Tommaso, et al.
Publicado: (2023)

RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer
por: Matsumoto, Akio, et al.
Publicado: (2020)

Restoring Radioiodine Uptake in BRAF V600E–Mutated Papillary Thyroid Cancer
por: Huillard, Olivier, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qoaeo58g4hl48h8umocapr4n94